Eli Lilly and Company is a global pharmaceutical company with extensive capabilities and expertise in the development of small and large molecule (e.g.,antibodies,proteins,peptides) therapeutics.Lillys internal research concentrates mainly in the Endocrine/Metabolism,Neuroscience,Oncology,Musculoskeletal,Autoimmune and Cardiovascular therapeutic areas and enhances the productivity of its intemal R&D efforts with cutting edge,innovative technologies and tools.Partnering and collaborations is a strategic growth imperative.At Eli Lilly,we are exploring novel partnership strategies across all stages of pharmaceutical research and development to work with outstanding partners around the globe to bring innovative medicines that improve patient outcomes to market.Eli Lillys Global External Research and Development (GER&D) Organization leads the identification and assessment of potential partnering efforts with external institutions and companies,performs technical and scientific assessments,and due diligences.